• DOI:10.1517/13543784.10.5.943
Corpus ID: 39820875

The spironolactone renaissance

@article{Doggrell2001TheSR,
  title={The spironolactone renaissance},
  author={S. Doggrell and Lindsay Brown},
  journal={Expert Opinion on Investigational Drugs},
  year={2001},
  volume={10},
  pages={943 - 954}
}

• S. Doggrell, Lindsay Brown
• Published 2001
• Medicine
• Expert Opinion on Investigational Drugs

Until recently, spironolactone was considered only as an antagonist at the aldosterone receptors of the epithelial cells of the kidney and was used clinically in the treatment of hyperaldosteronism and, occasionally, as a K+-sparing diuretic. The spironolactone renaissance started with the experimental finding that spironolactone reversed aldosterone-induced cardiac fibrosis by a cardiac action. Experimentally, spironolactone also has direct effects on blood vessels. Spironolactone reduces… Expand